[MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions

Growing biopharmaceutical company MeMed Diagnostics Ltd. is transforming the way doctors have traditionally treated infections by looking to the body’s immune system for answers.

Read more here.

The post [MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions appeared first on OurCrowd Blog.

OurCrowd Blog

Fintech unicorn Robinhood under regulatory scrutiny over March outage – Business Insurance

Fintech unicorn Robinhood under regulatory scrutiny over March outage  Business Insurance
“nigeria startups when:7d” – Google News

Fintech unicorn Robinhood under regulatory scrutiny over March outage – Business Insurance

Fintech unicorn Robinhood under regulatory scrutiny over March outage  Business Insurance
“nigeria startups when:7d” – Google News

[OurCrowd in Crowdfund Insider] Israel Is Reportedly Preparing to Finally Roll Out its Fintech Regulatory Sandbox Program, which is Part of Proposals in New Arrangements Law

Israel-based OurCrowd, the world’s largest investment crowdfunding platform, recently announced the launch of a $ 100 million Pandemic Innovation Fund. The Fund will invest in both new startups and certain companies already included in OurCrowd’s existing portfolio.

Read more here.

The post [OurCrowd in Crowdfund Insider] Israel Is Reportedly Preparing to Finally Roll Out its Fintech Regulatory Sandbox Program, which is Part of Proposals in New Arrangements Law appeared first on OurCrowd.

OurCrowd

Nigerian fintech startups may soon need regulatory approval to launch new products – Ventureburn

Nigerian fintech startups may soon need regulatory approval to launch new products  Ventureburn
“nigeria startups when:7d” – Google News

Nigerian fintech startups may soon need regulatory approval to test new products – Techpoint.ng

Nigerian fintech startups may soon need regulatory approval to test new products  Techpoint.ng
“nigeria startups when:7d” – Google News

[MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions

Israeli health company MeMed Diagnostics Ltd., which developed a test that can identify whether an infection was caused by a virus or bacteria thus significantly reducing the use of antibiotics for treatment, has received regulatory approval to put its rapid test, which can provide results within 15 minutes, on the Israeli and European market.

Read more here.

The post [MeMed in CTech] MeMed Receives Regulatory Green Light for Test that can Greatly Reduce Antibiotics Prescriptions appeared first on OurCrowd.

OurCrowd